By in-house counsel, for in-house counsel ®

Online Learning Center

From Trials to Market: Litigation Risks and Strategies for Life Sciences Companies (On-Demand)

Recorded On: 03/05/2025

  • Register
    • Non-member - $40
    • Member - Free!
    • *Further discounts may apply once you log in.

    Continue

image

This program originally aired on March 6, 2025. Please note that this program recording is not eligible for CLE/CPD credit.

Litigation risk is a constant concern for life sciences companies, from clinical trials to commercialization. This session will explore key litigation triggers across the product lifecycle and provide practical strategies for in-house counsel to mitigate risk. Through real-world case studies, our panel will share best practices for assessing and managing litigation exposure to protect both products and business operations.

Presented by:

John Alden
General Counsel
FibroGen

Janet Kwuon
Global Head of Litigation and Investigations
Gilead

Alicia Donahue
Partner
Shook Hardy

Lori McGroder
Partner
Shook Hardy

Tom Sullivan
Managing Partner, Boston
Shook Hardy


image
Components visible upon registration.

This program recording is not eligible for CLE/CPD.